|
|
| Clinical Research As A Delicate Ecosystem | Making the right outsourcing decision can significantly contribute to the success and growth of your program, providing essential support and resources that empower it to thrive in its objectives and endeavors. Entrust that your program is in hands you can rely on, where integrity is paramount, and excellence is the standard. |
|
|
|
|
By Tyler Menichiello, contributing editor | There’s an explosion of clinical activity in the gene therapy space for inherited retinal diseases (IRDs). Atsena Therapeutics' CMO, Dr. Kenji Fujita, explains what makes IRDs such appealing gene therapy targets and shares the company’s strategic approach to clinical development. |
|
|
|
| Exploring Osmolality As A CQA Within RNA Therapeutics | Poster | By Kendal Studd, Advanced Instruments, Inc. | Discover how osmolality can be applied throughout the bioprocessing workflow for RNA, and recognize the importance of this measurement, from formulation optimization to cryopreservation techniques. |
|
|
|
| Optimizing And Scaling Lentiviral Vector Production | Application Note | MilliporeSigma | Here, we outline how the upstream and downstream workflows of the VirusExpress® platform for lentiviral vectors were optimized through the use of design of experiments and supplementary studies. |
|
|
| How Cell And Gene Therapies Are Evolving | Article | Terumo BCT | Advances in manufacturing technologies and equipment are improving the efficiency and reproducibility of cell and gene therapies and helping overcome the current supply and demand imbalance. |
|
|
|
|
|
|
|
|
|
| Enable Custom Chromatography Solutions For Downstream Processing | Poster | By Frank Detmers, Pim Hermans, et al., Thermo Fisher Scientific Bioproduction | This study explores the development of a POROS prototype resin, investigating ligand immobilization, optimizing coupling conditions, and evaluating bead morphology impact on resin performance. |
|
|
| The Execution Stage Of Technology Transfer | Article | By Robert Ossig, CAI | What are the key elements in the readiness stage of a technology transfer that are critical to your success? Explore Process Performance Qualification (PPQ) and the execution stage of PDA TR-65. |
|
|
|
|
|
| KSQ Therapeutics' CSO, Micah Benson, Ph.D., joins Cell & Gene: The Podcast host, Erin Harris, to discuss how Tumor-Infiltrating Lymphocytes (TILs) as a treatment modality have the potential to treat a variety of solid tumor types. Benson explains KSQ's Phase 1/2 clinical study, KSQ-001EX, which consists of TILs in which the SOCS1 gene is inactivated by CRISPR/Cas9 gene editing. Listen now and subscribe so you never miss an episode! |
|
|
|
|
|
|
|
|
|
| Connect With Cell & Gene: |
|
|
|
